UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of combining UCN-01 with gemcitabine in treating
patients who have unresectable or metastatic pancreatic cancer. Drugs used in chemotherapy
use different ways to stop tumor cells from dividing so they stop growing or die. UCN-01 may
help gemcitabine kill more cancer cells by making tumor cells more sensitive to the drug